share_log

Champions Oncology Q1 EPS $(0.02) Misses $0.01 Estimate, Sales $13.74M Beat $13.19M Estimate

Champions Oncology Q1 EPS $(0.02) Misses $0.01 Estimate, Sales $13.74M Beat $13.19M Estimate

冠军肿瘤学第一季度每股收益0.02美元低于预期0.01美元,销售额1374万美元超过预期1319万美元
Benzinga Real-time News ·  2022/09/08 16:02

Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.01 by 300 percent. This is a 300 percent decrease over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $13.74 million which beat the analyst consensus estimate of $13.19 million by 4.21 percent. This is a 22.15 percent increase over sales of $11.25 million the same period last year.

冠军肿瘤公司(纳斯达克股票代码:CSBR)公布季度亏损为每股0.02美元,低于分析师一致预期的0.01美元,跌幅为300%。这比去年同期每股0.01美元的收益下降了300%。该公司公布的季度销售额为1374万美元,比分析师普遍预期的1319万美元高出4.21%。这比去年同期1125万美元的销售额增长了22.15%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发